Search Results for: elsevier

Weekend reads: Biotech CEO on leave after allegations on PubPeer; a researcher disavows his own paper; plagiarism here, there, and everywhere

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: ‘A costly mistake’ prompts retraction of paper on hair loss … Continue reading Weekend reads: Biotech CEO on leave after allegations on PubPeer; a researcher disavows his own paper; plagiarism here, there, and everywhere

Publisher retracts 20 of a researcher’s papers — then asks him to peer review

Fool me once, shame on you; fool me twice, shame on me. So the saying goes.  What about fool me 20 times? In December of last year, Dove Press — a unit of Taylor & Francis — retracted 14 papers by Marty Hinz, a Minnesota physician who has been sanctioned by the U.S. FDA as … Continue reading Publisher retracts 20 of a researcher’s papers — then asks him to peer review

Exclusive: Six years after a misconduct investigation, more than half of suspect papers remain unflagged

When the University of Colorado at Denver completed an investigation in 2015 into the work of a former faculty member, the school recommended that nine papers be corrected or retracted. But six years after the close of that investigation, the researcher, urologist Hari Koul, has had just two papers retracted and one corrected.  Multiple journal … Continue reading Exclusive: Six years after a misconduct investigation, more than half of suspect papers remain unflagged

The peer reviewers and editor wanted to publish my paper. The legal team rejected it.

Move over, Reviewer 2: The legal reviewer wants your job.  Last month, I was relieved when the journal Research Ethics published my article, “The Use of Confidentiality and Anonymity Protections as a Cover for Fraudulent Fieldwork Data.” One unexpected hurdle had almost thwarted publication. The problem wasn’t with the proverbial hard-to-please peer reviewer called Reviewer … Continue reading The peer reviewers and editor wanted to publish my paper. The legal team rejected it.

Weekend reads: Gibberish papers persist; the academic who faked Cherokee heritage; ‘organised fraud hits scientific journals’

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: ‘Regrettably it took too long to investigate and retract this … Continue reading Weekend reads: Gibberish papers persist; the academic who faked Cherokee heritage; ‘organised fraud hits scientific journals’

How hijacked journals keep fooling one of the world’s leading databases

It keeps happening.  There was the case of Talent Development and Excellence, which cloned an existing journal and managed to index hundreds of articles in Scopus, one of the world’s leading databases for scholarly literature. The Transylvanian Review did the same thing, and so did Test Engineering and Management. These journals — which can make … Continue reading How hijacked journals keep fooling one of the world’s leading databases

Oh, the gall(stones): A journal should retract a paper on reiki and pain, says a critic

Talk about missing the trees for the, ahem, forest plots. A researcher is accusing an Elsevier journal of refusing to retract a study that depends in large part on a flawed reference.  The paper, “The effect of Acupressure and Reiki application on Patient’s pain and comfort level after laparoscopic cholecystectomy: A randomized controlled trial,” appeared … Continue reading Oh, the gall(stones): A journal should retract a paper on reiki and pain, says a critic

Clinical trial paper that made anemia drug look safer than it is will be retracted

A study that a pharmaceutical company admitted last month included manipulated data will be retracted, Retraction Watch has learned. The paper, “Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis,” was published in Kidney International Reports in December 2020. The study analyzed data from a clinical trial for roxadustat, a … Continue reading Clinical trial paper that made anemia drug look safer than it is will be retracted

Years after faked peer review concerns surfaced, journals are still falling for it

A group of authors has lost a pair of papers in a computing journal for monkeying with the peer review process.  The first author on both articles was Mohamed Abdel-Basset of the Department of Operations Research in the Faculty of Computers and Informatics at Zagazig University, in Sharqiya. Mai Mohamad, also of Zagazig, is the … Continue reading Years after faked peer review concerns surfaced, journals are still falling for it

Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

One of China’s leading scientists in the fight against COVID-19 failed to disclose ties to a pharmaceutical company in a paper stemming from a clinical trial, Retraction Watch has learned. A co-author on the paper is married to the daughter of that pharmaceutical company’s founder, who herself sits on the firm’s board of directors.  Nanshan … Continue reading Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper